1.Growth Factors of Chinese Pharmaceutical Industry:An Empirical Study
China Pharmacy 2007;0(34):-
OBJECTIVE:To analyze the main factors affecting the growth of Chinese pharmaceutical industry so as to provide reference for government and pharmaceutical enterprises in decision making. METHODS: An empirical study was performed from aspects of technology innovation and elements of production by literature reviewing and regression modeling. RESULTS & CONCLUSIONS: The technology innovation has significantificant influence on the growth of Chinese pharmaceutical industry, and the investment in elements of production especially capital has positive influence on the development of Chinese pharmaceutical industry. It is suggested to protect intellectual property rights during technology innovation in order to ensure it’s the positivity on technology innovation.
2.Determination of Principal Components in Levofloxacin Hydrochloride Ointment by HPLC
Xianhong ZOU ; Wei PENG ; Yongjun XIAO ; Meirong ZHU
China Pharmacy 2001;0(12):-
OBJECTIVE:To establish a HPLC method for the determination of levofloxacin hydrochloride in the levoflo_ xacin hydrochloride ointment.METHODS:The chromatographic column was C 18 ,the mobile phase was consisted of0.05mol/L citric acid-acetonitrile(85∶15)with detection wavelength at293nm and flow speed at1.0ml/min,the column temperature was40℃and the sample size was10?l.RESULTS:Good linear relation was achieved when the levofloxacin hydrochloride concen-tration was at the range of3.88~37.88ug/ml(r=0.9998);The average recovery was99.4%(n=9).CONCLUSION:This determination method is accurate,reliable and it can act as an effective quality control for levofloxacin hydrochloride ointment.
3.Hippocampal corticotropin releasing hormone mRNA expression and neuroprotective mechanism of adrenocorticotropic hormore in immature rats after N-methyl-D-aspartate induced spasm seizures
Lei WANG ; Baoqin GAO ; Liping ZOU ; Xianhong LIANG ; Chunmei YAO ; Yajie WANG
Chinese Journal of Neuromedicine 2017;16(4):325-328
Objective To study the hippocampal corticotropin releasing hormone (CRH) mRNA expression and neuroprotective mechanism of adrenocorticotropic hormore (ACTH) in immature rats after N-methyl-D-aspartate (NMDA)-induced spasm seizures.Methods Sixty 10-day-old Wistar rats were randomly divided into blank control group,NMDA-induced seizure group and ACTH treatment group (n=20).Rats in the blank control group did not give any treatment;rat models of infantile spasm in the NMDA-induced seizure group and ACTH treatment group were induced by intraperitoneal injection of NMDA (7 mg/kg) for a consecutive 7 d;3 h after NMDA injection,intraperitoneal injection of ACTH 0.5 mg/(kg· d) was performed in the rats of ACTH treatment group,and NMDA-induced seizure group was given an equal volume of saline.By in situ hybridization (ISH),the mean optical density of CRH mRNA-positive neurons in the hippocampus was measured.Results In the ACTH treatment group,the latencies of epileptic seizures one week after treatment were significantly prolonged as compared with those before treatment,and the scores of epileptic seizures one week after treatment were significantly decreased as compared with those before treatment (P<0.05);the latencies of epileptic seizures were significantly prolonged and the scores of epileptic seizures were significantly decreased in the ACTH treatment group as compared with those in the NMDA-induced seizure group (P<0.05).The CRH mRNA expression in NMDA-induced seizure group was significantly increased as compared with that in the blank control group (P<0.05),and the CRH mRNA expression in the ACTH treatment group was significantly decreased as compared with that in the NMDA-induced seizure group (P<0.05).Conclusion Systemic ACTH has neuroprotective effect via down-regulating the hippocampal CRH mRNA expression.